VALENCIA, Calif. and MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and ...
In both studies, upadacitinib met the coprimary endpoints of T-VASI 50 and F-VASI 75 at week 48 vs placebo. Topline data were announced from 2 replicate phase 3 studies evaluating upadacitinib in ...
Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in this ...
In its second approval this month from the U.S. FDA, Avita Medical Inc.’s Recell system received premarket approval for the repigmentation of stable depigmented vitiligo lesions. The approval marks ...
Ruxolitinib cream for vitiligo showed 60% of patients maintained benefits post-treatment, with potential for skin repigmentation upon reinitiation. JNJ-2113 demonstrated significant efficacy in plaque ...
In its second approval this month from the U.S. FDA, Avita Medical Inc.’s Recell system received premarket approval for the repigmentation of stable depigmented vitiligo lesions. The approval marks ...
CARLSBAD, Calif. — When patients with vitiligo see Jessica Shiu, MD, PhD, for the first time, some mention that prior healthcare providers have told them that vitiligo is merely a cosmetic issue — ...
In a survey of pediatric patients with vitiligo, only 51.4% were offered narrowband ultraviolet B (NB-UVB) phototherapy, and 45.1% received this treatment before the age of 18 years. The main barriers ...
The MarketWatch News Department was not involved in the creation of this content. HORSHAM, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ: SSKN) ...
This article is sponsored by Incyte. Vitiligo is a chronic autoimmune condition that manifests as white patches of depigmented skin, or a complete loss of color, on affected areas of the body. The ...
Sam and Rissa were compensated for their participation. When Sam’s teacher asked, “What’s all over your face?” – it was a moment that stayed with her. Sam lives with vitiligo, a chronic autoimmune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results